Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

FDA greenlights updated COVID shots, prepares for fall rollout - Roll Call

The FDA approved updated COVID-19 vaccines for the 2024-25 season, preparing for an expected spike in cases this fall and winter.

Roll Call · Aug 22, 2024

Infectious diseases spike when kids return to school − here’s what you can do about it

Ready or not, back-to-school season is here, and kids will be bringing home more than homework. They’ll be carrying germs, too.

The Conversation · Aug 9, 2024

Top recruiters and CHROs from Moderna, Hilton, PwC say these are the 6 ways to stand out in a cooling job market

Job seekers need to hone a personal brand, upskill themselves, and stay resilient.

Fortune · Aug 5, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna's Quarterly Earnings Preview: What You Need to Know

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

Barchart · Jul 18, 2024

Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

The Conversation · Jul 16, 2024

Bird flu vaccines in development

As part of the Biden admin's pandemic preparedness strategy, Moderna will develop an mRNA vaccine for H5N1

Salon · Jul 3, 2024

Is Moderna Stock Outperforming the S&P 500?

Moderna recently outperformed the S&P 500, and Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart · Jun 19, 2024

Read news from The Economist, FT, and more,
with one subscription

Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health

Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza.

The Conversation · Jun 14, 2024

2-in-1 shot for flu and COVID shows promise in advanced trial

The pharmaceutical company Moderna announced promising results from the ongoing trial of its new vaccine, mRNA-1083.

LiveScience · Jun 10, 2024

Moderna combi flu and Covid jab gives better protection, study finds

Clinical trials show two-in-one jab may bring about higher immune responses than separate inoculations

The Guardian - UK · Jun 10, 2024

Combined Covid and flu vaccine could be approved for use on NHS by next year

New vaccine could cut need for separate Covid and flu jabs

The Independent UK · Jun 10, 2024

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall

The Independent UK · Jun 5, 2024

‘Extremely impressive’: melanoma jab trial results excite doctors

Vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinician

The Guardian - UK · Jun 3, 2024

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

Salon · Jun 1, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · May 31, 2024

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

Barchart · May 30, 2024

Is This Biotech Stock's OpenAI Partnership a Game-Changer?

With AI making waves in biotech, could this biotech’s OpenAI partnership be the catalyst for new highs?

Axios · May 10, 2024

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

AAP · Apr 17, 2024

Coroner probes vaccine link to young woman's death

A Victorian coroner is investigating whether a woman's death from heart inflammation after receiving her third COVID-19 jab was due to the Moderna vaccine.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · Mar 15, 2024

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

The Guardian - UK · Mar 12, 2024

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

Barchart · Mar 11, 2024

Stocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed -0.37%. Stocks Monday traded mildly lower on a +2.3 bp rise in the 10-year T-note...

StockNews.com · Feb 20, 2024

Moderna (MRNA) Earnings Analysis: Buy or Watch for Gains?

Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19 vaccine, steep losses, and cash burn reflect uncertainty around its near-term prospects. As MRNA is set to release its fourth-quarter 2023 results this Thursday, let’s find…

StockNews.com · Feb 13, 2024

Moderna (MRNA) and Biogen (BIIB) - Are There Upsides Left in These Biotech Stocks?

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, adaptability, and technological advancements, demonstrating resilience. So, let’s analyze the upside potential of popular biotech stocks Biogen (BIIB) and Moderna (MRNA).

LiveScience · Feb 8, 2024

New mRNA 'cancer vaccine' trial launches in UK

The first U.K. patient has received a dose of "cancer vaccine" in a new trial.

StockNews.com · Jan 19, 2024

Moderna (MRNA) vs. Exelixis (EXEL) - Which Biotech Stock Is Worth Buying?

The biotech industry is poised for long-term growth, supported by the advancements in personalized medicine and integration with information technology. While leading biotech stocks Moderna (MRNA) and Exelixis (EXEL) should benefit from the industry tailwinds, let us predict which stock is worth buying.

1 … 10 11 12 13

Coverage From

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.